ARTICLE | Company News
Wilex, Roche deal
September 21, 2015 7:00 AM UTC
Wilex said that Roche terminated a 2013 deal with Wilex’s Heidelberg Pharma GmbH subsidiary to develop antibody-targeted amanitin conjugates (ATACs) for cancer. Wilex said Roche terminated the deal du...